Read more
List of contents
1. In Vivo Activities of NK Cells Against Primary and Metastatic Tumors in Experimental Animals 2. The Involvement of Natural Killer Cells in Human Malignant Disease 3. Impaired NK Cell Profile in Leukemia Patients 4. In Vivo Modulation of NK Activity in Cancer Patients 5. The Implications of Aberrant Natural Killer (NK) Cell Activity in Nonmalignant Chronic Diseases 6. NK Cell Role in Regulation of the Growth and Functions of Hemopoietic and Lymphoid Cells 7. Natural Killer Cells Active Against Viral, Bacterial, Protozoan, and Fungal Infections 8. Cytokine Secretion and Noncytotoxic Functions of Human Large Granular Lymphocytes 9. Augmentation of Natural Killer Activity 10. Regulation of NK Cell Activity by Suppressor Cells 11. NK Cell Cloning Technology and Characteristics of NK Cell Clones 12. A Comparison of Antibody-Dependent Cellular Cytotoxicity (ADCC) and NK Activity
About the author
Dr. Eva Lotzova is Professor of Immunology, Chief of the Division of Immunologenetics at the University of Texas System Cancer, M.D. Anderson Hospital and Tumor Institute, Houston.
Dr. Ronald B. Herberman, formerly Chief of Biological Therapeutics Branch and Acting Associate Director for the Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute, Frederick, Maryland.
Summary
First published in 1986: This book contributes to the advancing knowledge of reads in the field of NK cells, and will be helpful as a teaching device.
